Pharmacotherapy for the management of cancer regimen-related oral mucositis
Introduction: Oral mucositis is a frequent and devastating toxicity secondary to cancer
treatment, which may affect 20–40% of patients receiving conventional chemotherapy and …
treatment, which may affect 20–40% of patients receiving conventional chemotherapy and …
Pharmacotherapy for the management of cancer regimen-related oral mucositis.
A Villa, ST Sonis - Expert Opinion on Pharmacotherapy, 2016 - europepmc.org
Oral mucositis is a frequent and devastating toxicity secondary to cancer treatment, which
may affect 20-40% of patients receiving conventional chemotherapy and 60-85% of patients …
may affect 20-40% of patients receiving conventional chemotherapy and 60-85% of patients …
Pharmacotherapy for the management of cancer regimen-related oral mucositis
A Villa, ST Sonis - Expert opinion on pharmacotherapy, 2016 - pubmed.ncbi.nlm.nih.gov
Introduction Oral mucositis is a frequent and devastating toxicity secondary to cancer
treatment, which may affect 20-40% of patients receiving conventional chemotherapy and 60 …
treatment, which may affect 20-40% of patients receiving conventional chemotherapy and 60 …
[引用][C] Pharmacotherapy for the management of cancer regimen-related oral mucositis
A Villa, ST Sonis - Expert Opinion on Pharmacotherapy, 2016 - cir.nii.ac.jp
Pharmacotherapy for the management of cancer regimen-related oral mucositis | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Pharmacotherapy for the Management of Cancer Regimen-Related Oral Mucositis.
A Villa - Expert Opinion on Pharmacotherapy, 2016 - baptisthealth.elsevierpure.com
Introduction: Oral mucositis is a frequent and devastating toxicity secondary to cancer
treatment, which may affect 20-40% of patients receiving conventional chemotherapy and 60 …
treatment, which may affect 20-40% of patients receiving conventional chemotherapy and 60 …